Company Profiles

driven by the PitchBook Platform

CureDM

CureDM
2004 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series C2 LATEST DEAL TYPE
$2.1M LATEST DEAL AMOUNT
3 INVESTORS
Description

Provider of biopharmaceutical services intended to prevent diabetes. The company's biopharmaceutical services develop therapies that can prevent, ameliorate and reverse diabetes and help to discontinue the use of insulin, enabling diabetic patients to get treatment without using painful insulin injections.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
1201 North Market Street
Suite 701
Wilmington, DE 19801
United States

+1 (302) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore CureDM’s full profile, request a free trial.

CureDM Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series C2) 10-Aug-2009 $2.1M 00.000 000.00 Completed Generating Revenue
4. Debt - General 28-Jan-2009 00000 00.000 Completed Generating Revenue
3. Debt - General 27-Feb-2008 00000 00.000 Completed Startup
2. Early Stage VC (Series B) 30-Nov-2006 $2.5M $2.79M Completed Startup
1. Early Stage VC (Series A) 22-Nov-2005 $290K $290K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

CureDM Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C2 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series C1 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 2,469,711 $0.001000 $1.24 $1.24 1x $0.78 13.55%
Series A 1,463,483 $0.001000 $0.5 $0.5 1x $0.48 5.22%
To view this company’s complete Cap Table, request access »

CureDM Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Calvert Research Institute Venture Capital Minority 000 0000 000000 0
Scientific Health Development Venture Capital Minority 000 0000 000000 0
Individual Investor Angel (individual) Minority 000 0000 000000 0

CureDM Executive Team (6)

Name Title Board
Seat
Contact
Info
Loraine Upham Co-Founder, Co-Chairman, President and Chief Executive Officer
Rita El-Hajj MD Co-Founder & Scientific Director
Claresa Levetan MD Co-Founder, Director & Chief Medical Officer
Joseph Reiser Ph.D Co-Chairman

2 Former Executives

You’re viewing 4 of 6 executives. Get the full list »

CureDM Board Members (9)

Name Representing Role Since Contact
Info
Carter Meyer JD Self Board Member 000 0000
Claresa Levetan MD CureDM Co-Founder, Director & Chief Medical Officer 000 0000
I. Wistar Morris III Self Board Member 000 0000
John Amatruda MD Self Board Member & Scientific Advisor 000 0000
John Dillon III Self Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »
Questions or concerns about this profile? Reach out to website-support@pitchbook.com